A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2002
12/03/2002	US6489356 Method for treating pain in humans
12/03/2002	US6489355 Therapy for alzheimer's disease
12/03/2002	US6489353 Antiinflammatory agents; autoimmune diseases; central nervous system disorders
12/03/2002	US6489352 Antiepileptic agents; nervous system disorders
12/03/2002	US6489350 Methods for treating neuropathic pain using heteroarylmethanesulfonamides
12/03/2002	US6489349 Treating an autoimmune disorder with an alkylamine substituted pyridine
12/03/2002	US6489347 Process
12/03/2002	US6489346 Substituted benzimidazole dosage forms and method of using same
12/03/2002	US6489345 Treating diabetes mellitus in a mammal comprising administering a therapeutically effective amount of a 3-acylated pyricoxal analogue or a pharmaceutically acceptable acid addition salt thereof
12/03/2002	US6489344 For treatment diabetes in a human or animal subject
12/03/2002	US6489341 Reducing or avoiding adverse effects associated with the administration of sertindole, by administrating a sertindole derivative such as nor-sertindole, 5-oxo-sertindole, dehydro-sertindole or dehydro-nor-sertindole
12/03/2002	US6489340 Macrolide compounds for inducing chondrogenic differentiation
12/03/2002	US6489339 C3A receptor ligands
12/03/2002	US6489338 Imidazopyridine and imidazopyrimidine antiviral agents
12/03/2002	US6489337 Treatment of alzheimer's disease, epilepsy, eating disorders, learning and memory disorders, migraine, sleep/wake disorders, allergic rhinitis, schizophrenia, mild cognitive impairment, and asthma
12/03/2002	US6489335 Providing tacrolimus in a pharmaceutically acceptable formulation for treating the disease
12/03/2002	US6489333 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
12/03/2002	US6489332 A1 adenosine receptor antagonists
12/03/2002	US6489331 Remedies for diabetes
12/03/2002	US6489330 Or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of such as famciclovir; prophylactic treatment for kaposi's sarcoma or aids related disease
12/03/2002	US6489329 Pharmaceutical compositions for the treatment of rhinitis
12/03/2002	US6489328 Heterocyclic compounds useful as inhibitors of tyrosine kinases
12/03/2002	US6489327 Tryptase inhibitors
12/03/2002	US6489326 Sodium nucleinate, 2-amino-1,2,3,4-tetrahydrophthalazine-1,4-dione sodium salt dihydrate, used as an immunomodulator, which also has antiinflammatory and antioxidant properties
12/03/2002	US6489324 Piperazine compounds as inhibitors of MMP or TNF
12/03/2002	US6489323 Inhibiting no production from l-arginine, as seen in disease states such as arthritis and systemic hypotension associated with septic and/or toxic shock
12/03/2002	US6489322 Benzoxazepines as selective inhibitors of the neuronal isoform of nitric oxide synthase for treatment of neurodegenerative disease
12/03/2002	US6489321 Nonpeptide substituted benzothiazepines as vasopressin antagonists
12/03/2002	US6489320 5, 5-disubstituted-1, 5-dihydro-4, 1-benzoxazepin-2 (3H)-ones useful as HIV reverse transcriptase inhibitors
12/03/2002	US6489319 Psychological disorders; cognition activators
12/03/2002	US6489318 Ethylidene derivatives of tricyclic carbapenems
12/03/2002	US6489316 Beta-lactamase inhibitor; antibiotics
12/03/2002	US6489313 Improving the memory of a mammal with impaired memory due to aging, wherein said mammal has no diagnosed disease or disorder known to impair memory by administering delta 5-androstene-3 beta-ol-7,17-dione and 3 beta esters thereof
12/03/2002	US6489312 Treating a patient having cancer from the toxicities associated with radio- or chemotherapy using amifostine and sodium deoxycholate
12/03/2002	US6489311 Using heparin or noncoagulant heparin in the prevention of apoptosis in ischemic-reperfused myocardium and/or brain
12/03/2002	US6489310 Enteral composition which comprises a protein source, a lipid source, a carbohydrate source, and a fibre blend comprising pea inner fibres, pea outer envelope fibres, inulin, and fructo-oligosaccharides
12/03/2002	US6489307 Reducing the level of transcription of beta 1-adrenoceptor polypeptide-specific mrna in a mammalian host cell, by administering oligonucleotide; reduces receptor expression; hypotensive effect
12/03/2002	US6489303 Anthelmintic composition
12/03/2002	US6489301 Solid pharmaceutical preparation for dialysis and a process for producing the same
12/03/2002	US6489300 Inhibitors of adhesion in the treatment of inflammatory brain diseases and other inflammatory conditions
12/03/2002	US6489289 Method for establishing a dosage plan for thrombin inhibitors
12/03/2002	US6489134 Kinesin motor modulators derived from the marine sponge Adocia
12/03/2002	US6489119 Analgesic screening method and composition
12/03/2002	US6488967 Gastric acid secretion
12/03/2002	US6488966 Administering a dose of elemental calcium that is effective to reduce carcinogenesis
12/03/2002	US6488964 Process for manufacturing coated gabapentin or pregabalin particles
12/03/2002	US6488960 Corticosteroid formulation
12/03/2002	US6488958 Hot melt self-adhesive composition comprises at least one hyperaemic active (circulation-promoting) substance; block copolymers of styrene and ethylene, propylene, butylene, butadiene, isoprene or mixtures thereof
12/03/2002	US6488954 Solid phase poloxamer mixture and polyethylene oxide or polyvinylpyrrolidone
12/03/2002	US6488953 Oral transmucosal delivery
12/03/2002	US6488951 Stable NO-delivering compounds
12/03/2002	US6488948 Cetrimonium chloride; benzalkonium chloride and grapefruit seed extract; didecyldimethyl ammonium chloride; quaternium surfactant; behentrimonium methosulfate and stearyl alcohol; sunscreen, coating for elastic glove, diaper, wipes
12/03/2002	US6488944 1, 1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane
12/03/2002	US6488943 Anionic surfactant; proton donating agent comprising 2-pyrrolidone-5 carboxylic acid
12/03/2002	US6488937 Allergy treatment method using a rapid immunotherapy protocol
12/03/2002	US6488928 Product for topical application containing a lipase and a hydroxy acid precursor
12/03/2002	US6488923 Inhibits elastase; inhibits inflammations; used for the preparation of a vasoregulatory and or collagen activating medicament and to treat gingivitis.
12/03/2002	US6488922 Applying 1-(n-(2'-nitro-4'-trifluoromethylphenyl)amino)-2,3-propylene to scalp
12/03/2002	US6488915 Use of sunscreen combinations which comprise, as essential constituent, 2-(4-alkoxyanilinomethylene) malonic dialkyl esters as photostable UV filters in cosmetic and pharmaceutical preparations
12/03/2002	US6488912 Treatment of dentoalveolar infections with taurolidine and/or taurultam
12/03/2002	US6488780 Detergent cosmetic compositions and use thereof
12/03/2002	US6488665 Antimicrobial alcohol gel pre-operative skin-preparation delivery system
12/03/2002	US6488164 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
12/03/2002	CA2283915C The use of alkyl hydrogen fumarates for treating psoriasis, psoriatic arthritis, neurodermatitis and enteritis regionalis crohn
12/03/2002	CA2266107C Aralkyl and aralkylidene heterocyclic lactams and imides
12/03/2002	CA2255748C Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
12/03/2002	CA2253061C A novel anti-allergy anti-inflammatory composition
12/03/2002	CA2228249C Pain-alleviating drug composition and method for alleviating pain
12/03/2002	CA2216617C New flavone derivatives, their preparation procedures and the pharmaceutical compositions containing them
12/03/2002	CA2213198C Gene therapy by anti-tgf-b agents
12/03/2002	CA2206837C Use of strontium salts to obtain pharmaceutical compositions intented for the treatment of arthrosis
12/03/2002	CA2126103C Transfection of lung via aerosolized transgene delivery
12/03/2002	CA2117543C Dipeptidylquinazolones as anti-cancer agents
12/03/2002	CA2099782C Optically active 5h-pyrrolo[3,4-b] pyrazine, preparation thereof and pharmaceutical compositions contaning same
12/03/2002	CA2095789C Transdermal administration system for estradiol
12/03/2002	CA2080705C Substituted pyrimidines
12/03/2002	CA2074933C Thiazole derivatives as active superoxide radical inhibitors
12/03/2002	CA2065644C Pyrazolopyridine compound and processes for preparation thereof
12/03/2002	CA2042668C Treatment of amyloidosis associated with alzheimer's disease
11/2002
11/30/2002	CA2389560A1 Cosmetic and/or dermatological and/or pharmaceutical compound for topical application, containing at least one 3 beta-hydroxysteroid dehydrogenase enzyme inhibitor
11/30/2002	CA2388287A1 Therapies for the prevention and treatment of diabetes and obesity
11/30/2002	CA2387821A1 Azalide antibiotic compositions
11/30/2002	CA2387699A1 Combination treatment for sleep disorders including sleep apnea
11/29/2002	CA2389552A1 Composition for the treatment of cutaneous signs of aging
11/28/2002	WO2002095704A1 Use of nf-kappa-b inhibitors to treat dry eye disorders
11/28/2002	WO2002095361A2 Identification of anti-protozoal agents
11/28/2002	WO2002095050A2 Trinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
11/28/2002	WO2002095034A2 A retinoic acid metabolizing cytochrome p450
11/28/2002	WO2002095027A2 Immunostimulatory oligodeoxynucleic molecules
11/28/2002	WO2002095020A1 A gene and uses therefor
11/28/2002	WO2002095015A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002	WO2002095007A2 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	WO2002095005A2 Therapeutic dna vaccination
11/28/2002	WO2002094879A1 Antibodies specific for cd44v6
11/28/2002	WO2002094861A2 Genes and proteins involved in the biosynthesis of enediyne ring structures
11/28/2002	WO2002094849A2 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process
11/28/2002	WO2002094845A2 Method for stabilising of nucleic acids
11/28/2002	WO2002094844A2 Antiviral nucleosides
11/28/2002	WO2002094840A2 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same

1 ... 5634 5635 5636 5637 5638 5639 5640 5641 5642 5643 5644 5645 5646 5647 5648 5649 5650 5651 5652 5653 5654 ... 7860